CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Regulatory T cells (Tregs) are often enriched in tumors, where their immunosuppressive function has a key role in tumor persistence and progression. In colorectal cancer (CRC), however, Tregs are frequently associated with an improved clinical outcome. Tumor-infiltrating Tregs have been shown to exhibit a distinct signature comprising the co-stimulatory molecules (OX40, 4-1BB), cytokine receptors (IL1R2, IL21R, CCR8, CD30), and co-inhibitory molecules (PD-L1, TIGIT). Here, we showed by flow cytometry that circulating CD45RO+Tregs from patients with CRC (n = 25) have elevated CD30 and OX40 expression compared to healthy subjects (n = 14). We identified co-expression of CD30 and OX40 on circulating CD45RO+Tregs using single-cell images captured by the DEPArray™system. The frequency of CD30+OX40+CD45RO+Tregs was significantly higher in CRC patients than in healthy subjects (P < 0.001). Importantly, receiver operating characteristic analysis confirmed that this CD30+OX40+Treg subset could strongly discriminate between CRC patients and healthy subjects with the highest accuracy of 92.3%, an AUC of 0.92, a sensitivity of 88%, a specificity of 100%, a positive predictive value of 100%, a negative predictive value of 82.35%, and a trade-off value of 3.44%, compared to other Treg subsets. Consistently, multiplex-IHC/IF of tumor-infiltrating Tregs revealed a significant association between high densities of CD30+OX40+Tregs and improved overall survival; no such association was found for other subsets. These data suggest a potential role for CD30+OX40+Tregs as a diagnostic or prognostic biomarker in CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tregs suppress the harmful inflammatory response and thus exhibit positive benefits in patients with several types of cancers, including colorectal cancer (CRC) and head and neck tumors (HNC) [16, 18–21].”
From Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review (2024) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tregs suppress microbial-induced inflammation, therefore decreasing susceptibility to tumors [16].”
From Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review (2024) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies on various types of malignant tumors, such as CRC, HNSCC, and gastric cancer (GC), have shown a positive correlation between Tregs infiltration and prolonged survival of cancer patients [16, 18, 20, 34, 35].”
From Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review (2024) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
FOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2785 · Cited by 2,439
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Lineage tracking reveals dynamic relationships of T cells in colorectal cancer
Zhang, L., Yu, X., Zheng, L., Zhang, Y., Li, Y., Fang, Q., Gao, R., Kang, B., Zhang, Q., Huang, J. Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0694-x · Cited by 1,505
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
PD-1 Blockade with pembrolizumab in advanced Merkel-cell carcinoma
Nghiem, P. T., Bhatia, S., Lipson, E. J., Kudchadkar, R. R., Miller, N. J., Annamalai, L., Berry, S., Chartash, E. K., Daud, A., Fling, S. P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603702 · Cited by 1,258
Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., & Banham, A. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9584 · Cited by 1,200
Tosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G., Berger, A., Bruneval, P., Fridman, W.-H., Pagès, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2907 · Cited by 1,146
Woo, E. Y., Chu, C., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., & June, C. H. (2001) · PubMed · Cited by 1,108
Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M. (2007) · European Journal of Immunology · doi:10.1002/eji.200636435 · Cited by 1,011
Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., Platell, C., & Iacopetta, B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 991
Lovisa, S., LeBleu, V. S., Tampe, B., Sugimoto, H., Vadnagara, K., Carstens, J. L., Wu, C.-C., Hagos, Y., Burckhardt, B. C., Pentcheva-Hoang, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3902 · Cited by 978
Joller, N., Lozano, E., Burkett, P. R., Patel, B., Xiao, S., Zhu, C., Xia, J., Tan, T. G., Sefik, E., Yajnik, V., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.012 · Cited by 955
Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K. (2007) · International Immunology · doi:10.1093/intimm/dxm014 · Cited by 872
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Saito, T., Nishikawa, H., Wada, H., Nagano, Y., Sugiyama, D., Atarashi, K., Maeda, Y., Hamaguchi, M., Ohkura, N., Sato, E., et al. (2016) · Nature Medicine · doi:10.1038/nm.4086 · Cited by 871
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Facciabene, A., Motz, G. T., & Coukos, G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3687 · Cited by 821
Stack, E. C., Wang, C., Roman, K. A., & Hoyt, C. C. (2014) · Methods · doi:10.1016/j.ymeth.2014.08.016 · Cited by 768
De Simone, M., Arrigoni, A., Rossetti, G., Gruarin, P., Ranzani, V., Politano, C., Bonnal, R. J. P., Provasi, E., Sarnicola, M. L., Panzeri, I., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.021 · Cited by 687
The significance of OX40 and OX40L to T‐cell biology and immune disease
Croft, M., So, T., Duan, W., & Soroosh, P. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00766.x · Cited by 604
Sasada, T., Kimura, M., Yoshida, Y., Kanai, M., & Takabayashi, A. (2003) · Cancer · doi:10.1002/cncr.11618 · Cited by 484
The TIGIT/CD226 Axis Regulates Human T Cell Function
Lozano, E., Dominguez-Villar, M., Kuchroo, V., & Hafler, D. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103627 · Cited by 476
Mlecnik, B., Bindea, G., Kirilovsky, A., Angell, H. K., Obenauf, A. C., Tosolini, M., Church, S. E., Maby, P., Vasaturo, A., Angelova, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad6352 · Cited by 472
Garnelo, M., Tan, A., Her, Z., Yeong, J., Lim, C. J., Chen, J., Lim, K. H., Weber, A., Chow, P., Chung, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310814 · Cited by 461
Self-citationdeLeeuw, R. J., Kost, S. E., Kakal, J. A., & Nelson, B. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3216 · Cited by 437
Duhen, T., Duhen, R., Lanzavecchia, A., Sallusto, F., & Campbell, D. J. (2012) · Blood · doi:10.1182/blood-2011-11-392324 · Cited by 413
Frey, D. M., Droeser, R. A., Viehl, C. T., Zlobec, I., Lugli, A., Zingg, U., Oertli, D., Kettelhack, C., Terracciano, L., & Tornillo, L. (2010) · International Journal of Cancer · doi:10.1002/ijc.24989 · Cited by 333
Immune evasion before tumour invasion in early lung squamous carcinogenesis
Mascaux, C., Angelova, M., Vasaturo, A., Beane, J., Hijazi, K., Anthoine, G., Buttard, B., Rothe, F., Willard-Gallo, K., Haller, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1330-0 · Cited by 331
Rationale for anti-OX40 cancer immunotherapy
Aspeslagh, S., Postel-Vinay, S., Rusakiewicz, S., Soria, J.-C., Zitvogel, L., & Marabelle, A. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.08.021 · Cited by 318
Role of 4-1BB in immune responses
Vinay, D. S., & Kwon, B. S. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0157 · Cited by 312
van der Weyden, C. A., Pileri, S. A., Feldman, A. L., Whisstock, J., & Prince, H. M. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.85 · Cited by 247
Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables
Sastre, J., Maestro, M. L., Puente, J., Veganzones, S., Alfonso, R., Rafael, S., García-Saenz, J. A., Vidaurreta, M., Martín, M., Arroyo, M., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm583 · Cited by 215
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
Le Gouvello, S., Bastuji-Garin, S., Aloulou, N., Mansour, H., Chaumette, M.-T., Berrehar, F., Seikour, A., Charachon, A., Karoui, M., Leroy, K., et al. (2008) · Gut · doi:10.1136/gut.2007.123794 · Cited by 214
Clarke, S. L., Betts, G. J., Plant, A., Wright, K. L., El-Shanawany, T. M., Harrop, R., Torkington, J., Rees, B. I., Williams, G. T., Gallimore, A. M., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000129 · Cited by 213
CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells.
Ellis, T. M., Simms, P. E., Slivnick, D. J., Jäck, H. M., & Fisher, R. I. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2380 · Cited by 203
Ling, K. L., Pratap, S., Bates, G. J., Singh, B., Mortensen, N. J. M., George, B. D., Warren, B. F., Piris, J., Roncador, G., Fox, S. B., et al. (2007) · PubMed · Cited by 191
Giraldo, N. A., Nguyen, P., Engle, E. L., Kaunitz, G. J., Cottrell, T. R., Berry, S., Green, B., Soni, A., Cuda, J. D., Stein, J. E., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0404-0 · Cited by 177
Multiparametric immune profiling in HPV– oral squamous cell cancer
Feng, Z., Bethmann, D., Kappler, M., Ballesteros-Merino, C., Eckert, A., Bell, R. B., Cheng, A., Bui, T., Leidner, R., Urba, W. J., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93652 · Cited by 175
Wei, X., Zhang, J., Gu, Q., Huang, M., Zhang, W., Guo, J., & Zhou, X. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.090 · Cited by 165
Sherwood, A. M., Emerson, R. O., Scherer, D., Habermann, N., Buck, K., Staffa, J., Desmarais, C., Halama, N., Jaeger, D., Schirmacher, P., et al. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1446-2 · Cited by 154
Yeong, J. P.-S., Thike, A. A., Lim, J. C. T., Lee, B. T. K., Li, H., Wong, S. C., Hue, S. S., Tan, P. H., & Iqbal, J. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4161-4 · Cited by 148
Self-citationYeong, J., Lim, J. C. T., Lee, B., Li, H., Chia, N., Ong, C. C. H., Lye, W. K., Putti, T. C., Dent, R., Lim, E., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01209 · Cited by 144
Self-citationCD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens.
Javia, L. R., & Rosenberg, S. A. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200301000-00009 · Cited by 135
COX-2 modulates mammary tumor progression in response to collagen density
Esbona, K., Inman, D., Saha, S., Jeffery, J., Schedin, P., Wilke, L., & Keely, P. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0695-3 · Cited by 127
Ling, A., Edin, S., Wikberg, M. L., Öberg, Å., & Palmqvist, R. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.161 · Cited by 111
Yeong, J. P.-S., Lim, J. C. T., Lee, B. T. K., Li, H., Ong, C. C. H., Thike, A. A., Yeap, W. H., Yang, Y. L., Lim, A. Y. H., Tay, T. K. Y., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0499-y · Cited by 108
Self-citationYoon, H. H., Orrock, J. M., Foster, N. R., Sargent, D. J., Smyrk, T. C., & Sinicrope, F. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042274 · Cited by 98
Viability and Functional Activity of Cryopreserved Mononuclear Cells
Weinberg, A., Zhang, L., Brown, D., Erice, A., Polsky, B., Hirsch, M., Owens, S., & Lamb, K. (2000) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.7.4.714-716.2000 · Cited by 96
Lim, J. C. T., Yeong, J. P.-S., Lim, C. J., Ong, C. C. H., Wong, S. C., Chew, V., Ahmed, S. S., Tan, P. H., & Iqbal, J. (2018) · Pathology · doi:10.1016/j.pathol.2017.11.087 · Cited by 88
Self-citationReimers, M. S., Engels, C. C., Putter, H., Morreau, H., Liefers, G. J., van de Velde, C. J., & Kuppen, P. J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-486 · Cited by 87
[Colorectal cancer screening].
Rj, L., & van Bochov, A. (2009) · PubMed · Cited by 77
Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
Lam, J. H., Ng, H. H. M., Lim, C. J., Sim, X. N., Malavasi, F., Li, H., Loh, J. J. H., Sabai, K., Kim, J.-K., Ong, C. C. H., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02093 · Cited by 72
Self-citationMultispectral Imaging of T and B Cells in Murine Spleen and Tumor
Feng, Z., Jensen, S. M., Messenheimer, D. J., Farhad, M., Neuberger, M., Bifulco, C. B., & Fox, B. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502635 · Cited by 70
Pickhardt, P. J. (2016) · Abdominal Radiology · doi:10.1007/s00261-016-0798-4 · Cited by 63
Abel, E. J., Bauman, T. M., Weiker, M., Shi, F., Downs, T. M., Jarrard, D. F., & Huang, W. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.01.008 · Cited by 62
Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry
Fiore, C., Bailey, D., Conlon, N., Wu, X., Martin, N., Fiorentino, M., Finn, S. P., Fall, K., Andersson, S., Andrén, O., et al. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200734 · Cited by 62
Amygdala unit activity during sleep and waking
Jacobs, B. L., & McGinty, D. (1971) · Experimental Neurology · doi:10.1016/0014-4886(71)90097-5 · Cited by 61
(2017) · PubMed · Cited by 60
Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice
Gaspal, F., Withers, D. R., Saini, M., Bekiaris, V., McConnell, F. M., White, A. J., Khan, M., Yagita∥, H., Walker, L. S. K., Anderson, G., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101484 · Cited by 59
Tokuno, K., Hazama, S., Yoshino, S., Yoshida, S., & Oka, M. (2009) · PubMed · Cited by 44
Chadburn, A., Inghirami, G., & Knowles, D. (1992) · PubMed · Cited by 36
Chan, P. W. W., Ngu, J. H., Poh, Z., & Soetikno, R. M. (2017) · Singapore Medical Journal · doi:10.11622/smedj.2017004 · Cited by 31
Suzuki, H., Onishi, H., Morisaki, T., Tanaka, M., & Katano, M. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.10.007 · Cited by 29
The course of transient ischemic attacks
Werdelin, L., & Juhler, M. (1988) · Neurology · doi:10.1212/wnl.38.5.677 · Cited by 27
Gaskie, S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7295-3775-9.50018-4 · Cited by 15
Nawaf, M. G., Ulvmar, M. H., Withers, D. R., McConnell, F. M., Gaspal, F., Webb, G. J., Jones, N. D., Yagita∥, H., Allison, J. P., & Lane, P. J. L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700088 · Cited by 6
Research works printed but not linked: 1
- Garnelo M, Tan A, Her Z, Yeong J, Lim CJ, Chen J, Lim KH, Weber A, Chow P, Chung A, Ooi LL, Toh HC, Heikenwalder M, Ng IO, Nardin A, Chen Q, Abastado JP, Chew V (2015) Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut 15(310814):2015–310814
Cited by
Therapeutic targeting of regulatory T cells in cancer
Shan, F., Somasundaram, A., Bruno, T. C., Workman, C. J., & Vignali, D. A. A. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2022.06.008 · Cited by 244
CD4+ T cells in antitumor immunity
Montauti, E. I., Oh, D. Y., & Fong, L. H. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.07.009 · Cited by 182
Regulatory T cells in the tumour microenvironment
Imianowski, C. J., Chen, Q., Workman, C. J., & Vignali, D. A. A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00832-9 · Cited by 158
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
Li, Y., Zhang, C., Jiang, A., Lin, A., Liu, Z., Cheng, X., Wang, W., Cheng, Q., Zhang, J., Wei, T., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05104-y · Cited by 105
Wang, Y., Li, J., Nakahata, S., & Iha, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137346 · Cited by 97
Metadata
- Authors
- Lam, J. H., Hong, M., Koo, S.-L., Chua, C. W. L., Lim, K. L., Wee, F., Wan, W. K., Leow, W. Q., Yeo, J. G., Tan, I. B. H., Yeong, J., Lim, T. K. H., & Lim, T. S.
- Affiliations
- National Cancer Centre Singapore (SG)
- Singapore General Hospital (SG)
- SingHealth Duke-NUS Academic Medical Centre (SG)
- Agency for Science, Technology and Research (SG)
- SingHealth (SG)
- Corresponding author
- Yeong, Joe
- Lim, Tony Kiat Hon
- Lim, Tong Seng
- ORCID
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2021-02-02
- Volume
- 70
- Issue
- 8
- Pages
- 2353-2365
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- PMC
- PMC8289785
- OpenAlex
- W3129005829
- Cited by
- 31
- References
- 68
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 8 · 2023: 6 · 2022: 6
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cancer Immunology Immunotherapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Singapore General Hospital
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- colorectal cancer, regulatory T cells, CD30, OX40, CD45RO, tumor-infiltrating Treg cells, prognostic factors, overall survival, tumor immunosuppression, diagnostic biomarkers, tumor-infiltrating immune cells
- MeSH terms
- Cells, Cultured, Humans, Prospective Studies, Retrospective Studies, Biomarkers, Tumor, Colorectal Neoplasms, Leukocyte Common Antigens, Ki-1 Antigen, Receptors, Cytokine, T-Lymphocytes, Regulatory, Receptors, OX40
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.